Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects
Year: 2023
Type: article
Abstract: Identifying effective therapeutic treatment strategies is a major challenge to improving outcomes for patients with breast cancer. To gain a comprehensive understanding of how clinically relevant anti-cancer agents modulate cell cycle progression, here we use genetically engineered breast cancer cell lines to track drug-induced changes in cell number and cell cycle phase to reveal drug-specific cell cycle effects that vary across time. We use a linear chain trick (LCT) computational model, which faithfully captures drug-induced dynamic responses, correctly infers drug effects, and reproduces influences on specific cell cycle phases. We use the LCT model to predict the effects of unseen drug combinations and confirm these in independent validation experiments. Our integrated experimental and modeling approach opens avenues to assess drug responses, predict effective drug combinations, and identify optimal drug sequencing strategies.
Source: Nature Communications
Language: English
Subfield: Modeling and Simulation
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $6,290
Funders: U.S. Department of Health and Human Services, Breast Cancer Research Foundation, Oregon Health and Science University, Jayne Koskinas Ted Giovanis Foundation for Health and Policy, Prospect Creek Foundation, National Institutes of Health, National Human Genome Research Institute, National Cancer Institute
Awards: Precision lung cancer therapy design through multiplexed adapter measurement, G2535433541, Measuring, Modeling and Controlling Heterogeneity, G529853901, G688163279, Extrinsic Perturbations of Cell Physiology and Associated Regulatory Networks, BD FACSAria Fusion for the OHSU Knight Flow Cytometry Shared Resource, OHSU Knight Cancer Institute
OpenAlex ID: W4380152018
